Batterham, Rachel L.
Eli Lilly (United Kingdom) · University College London
37 papers on CoChatORCID 0000-0002-5477-8585
Most cited papers
- Verified
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 5,205
- Verified
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature
Regulation of Appetite and ObesityNeuropeptides and Animal Physiology
Cited by 2,351
- Verified
Definition and diagnostic criteria of clinical obesity
Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology
Obesity and Health PracticesObesity, Physical Activity, Diet
Cited by 1,811
- Verified
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine
Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases
Cited by 1,604
- Verified
Joint international consensus statement for ending stigma of obesity
Rubino, F., Puhl, R. M., Cummings, D. E., Eckel, R. H., Ryan, D. H., Mechanick, J. I., Nadglowski, J., Ramos Salas, X., Schauer, P. R., Twenefour, D., et al. (2020) · Nature Medicine
Obesity and Health PracticesObesity, Physical Activity, Diet
Cited by 1,152
- Verified
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Oral, T. K., Rosenstock, J., et al. (2022) · Diabetes, Obesity and Metabolism
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 1,128
- Verified
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., et al. (2009) · Science
Genetics, Aging, and Longevity in Model OrganismsPI3K/AKT/mTOR signaling in cancer
Cited by 1,120
- Verified
Ghrelin
Müller, T. D., Nogueiras, R., Andermann, M. L., Andrews, Z. B., Anker, S. D., Argente, J., Batterham, R. L., Benoit, S. C., Bowers, C. Y., Broglio, F., et al. (2015) · Molecular Metabolism
Regulation of Appetite and ObesityGrowth Hormone and Insulin-like Growth Factors
Cited by 1,034
- Verified
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
Rubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Diabetes Care
Bariatric Surgery and OutcomesDiabetes Treatment and Management
Cited by 1,008
- Verified
Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters
Roux, C. W. L., Aylwin, S. J. B., Batterham, R. L., Borg, C. M., Coyle, F., Prasad, V., Shurey, S., Ghatei, M. A., Patel, A. G., & Bloom, S. R. (2006) · Annals of Surgery
Bariatric Surgery and OutcomesRegulation of Appetite and Obesity
Cited by 985
- Verified
Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity
Wahl, S., Drong, A., Lehne, B., Loh, M., Scott, W. R., Kunze, S., Tsai, P.-C., Ried, J. S., Zhang, W., Yang, Y., et al. (2017) · Nature
Epigenetics and DNA MethylationGenetic Associations and Epidemiology
Cited by 945
- Verified
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., et al. (2022) · Nature Medicine
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 868
- Verified
Advancing the global public health agenda for NAFLD: a consensus statement
Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., et al. (2022) · Nature Reviews Gastroenterology & Hepatology
Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects
Cited by 757
- Verified
Evidence for lifespan extension and delayed age–related biomarkers in insulin receptor substrate 1 null mice
Selman, C., Lingard, S., Choudhury, A. I., Batterham, R. L., Claret, M., Clements, M., Ramadani, F., Okkenhaug, K., Schuster, E., Blanc, E., et al. (2008) · The FASEB Journal
Genetics, Aging, and Longevity in Model OrganismsGrowth Hormone and Insulin-like Growth Factors
Cited by 532
- Verified
Pancreatic Polypeptide Reduces Appetite and Food Intake in Humans
Batterham, R. L., Le Roux, C. W., Cohen, M. A., Park, A. J., Ellis, S. M., Patterson, M., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · The Journal of Clinical Endocrinology & Metabolism
Regulation of Appetite and ObesityNeuropeptides and Animal Physiology
Cited by 496
- Verified
Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP
Di Lorenzo, N., Antoniou, S. A., Batterham, R. L., Busetto, L., Godoroja, D., Iossa, A., Carrano, F. M., Agresta, F., Alarçon, I., Azran, C., et al. (2020) · Surgical Endoscopy
Bariatric Surgery and OutcomesBody Contouring and Surgery
Cited by 465
- Verified
Mechanisms of diabetes improvement following bariatric/metabolic surgery
Batterham, R. L., & Cummings, D. E. (2016) · Diabetes Care
Bariatric Surgery and OutcomesDiabetes Treatment and Management
Cited by 376
- Verified
The role of peptide YY in appetite regulation and obesity
Karra, E., Chandarana, K., & Batterham, R. L. (2009) · The Journal of Physiology
Regulation of Appetite and ObesityNeuropeptides and Animal Physiology
Cited by 336
- Verified
Once-weekly cagrilintide for weight management in people with overweight and obesity: A multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Lau, D. C. W., Erichsen, L., Francisco, A. M., Satylganova, A., le Roux, C. W., McGowan, B., Pedersen, S. D., Pietiläinen, K. H., Rubino, D., & Batterham, R. L. (2021) · The Lancet
Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity
Cited by 278
- Verified
Effective strategies in ending weight stigma in healthcare
Talumaa, B., Brown, A., Batterham, R. L., & Kalea, A. Z. (2022) · Obesity Reviews
Obesity and Health PracticesObesity, Physical Activity, Diet
Cited by 250
- Verified
Acute and Chronic Effects of Exercise on Appetite, Energy Intake and Appetite-Related Hormones: the Modulating Effect of Adiposity, Sex and Habitual Physical Activity
Dorling, J., Broom, D., Burns, S., Clayton, D., Deighton, K., James, L., King, J., Miyashita, M., Thackray, A., Batterham, R., et al. (2018) · Nutrients
Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases
Cited by 235
- Verified
Pervasiveness, impact and implications of weight stigma
Brown, A., Flint, S. W., & Batterham, R. L. (2022) · eClinicalMedicine
Obesity and Health PracticesObesity, Physical Activity, Diet
Cited by 212
- Verified
Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
Miras, A. D., Pérez-Pevida, B., Aldhwayan, M., Kamocka, A., McGlone, E. R., Al-Najim, W., Chahal, H., Batterham, R. L., McGowan, B., Khan, O., et al. (2019) · The Lancet Diabetes & Endocrinology
Bariatric Surgery and OutcomesDiabetes Treatment and Management
Cited by 190
- Verified
Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial
Mok, J., Adeleke, M. O., Brown, A., Magee, C. G., Firman, C., Makahamadze, C., Jassil, F. C., Marvasti, P., Carnemolla, A., Devalia, K., et al. (2023) · JAMA Surgery
Bariatric Surgery and OutcomesPharmacology and Obesity Treatment
Cited by 178
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free